Pulmonx (LUNG) Capital Expenditures (2019 - 2025)

Pulmonx (LUNG) has 7 years of Capital Expenditures data on file, last reported at -$347000.0 in Q3 2025.

• On a quarterly basis, Capital Expenditures rose 60.16% year-over-year to -$347000.0 in Q3 2025; TTM through Sep 2025 was $181000.0, a 79.21% increase from a year earlier, with the FY2024 full-year figure at $218000.0, up 100.0% from the prior year.
• Capital Expenditures for Q3 2025 stood at -$347000.0, down from $58000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for LUNG reached as high as $3.6 million in Q4 2021 and fell as low as -$871000.0 in Q3 2021.
• Historically, Capital Expenditures has averaged $233421.1 across 5 years, with a median of $144000.0 in 2021.
• Across the five-year window, Capital Expenditures surged 425.11% in 2021 and sank 1277.03% in 2024, its largest moves.
• Year by year, Capital Expenditures stood at $3.6 million in 2021, then slumped by 119.7% to -$717000.0 in 2022, then surged by 107.25% to $52000.0 in 2023, then soared by 225.0% to $169000.0 in 2024, then sank by 305.33% to -$347000.0 in 2025.
• Per Business Quant data, the three most recent Capital Expenditures figures were -$347000.0 in Q3 2025, $58000.0 in Q2 2025, and $301000.0 in Q1 2025.